Literature DB >> 11751782

Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities.

Jeremy I Ross1, E Anne Eady, Ellen Carnegie, Jonathan H Cove.   

Abstract

Forty-five cutaneous propionibacterial isolates from six European cities were found to be highly resistant to all macrolide-lincosamide-streptogramin B antibiotics, including the ketolide telithromycin. This contrasts with previously documented phenotypes associated with 23S rRNA mutations. Sequencing of the resistance determinant showed it to be erm(X) of corynebacterial origin located on the composite transposon Tn5432.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11751782     DOI： 10.1093/jac/49.1.165

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  20 in total

1.  Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.

Authors:  Stefanie Heller; Laurenz Kellenberger; Stuart Shapiro
Journal:  Antimicrob Agents Chemother       Date:  2007-03-26       Impact factor: 5.191

2.  Complete genome sequence and analysis of the multiresistant nosocomial pathogen Corynebacterium jeikeium K411, a lipid-requiring bacterium of the human skin flora.

Authors:  Andreas Tauch; Olaf Kaiser; Torsten Hain; Alexander Goesmann; Bernd Weisshaar; Andreas Albersmeier; Thomas Bekel; Nicole Bischoff; Iris Brune; Trinad Chakraborty; Jörn Kalinowski; Folker Meyer; Oliver Rupp; Susanne Schneiker; Prisca Viehoever; Alfred Pühler
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

3.  Transferable Multidrug-Resistance Plasmid Carrying a Novel Macrolide-Clindamycin Resistance Gene, erm(50), in Cutibacterium acnes.

Authors:  Sae Aoki; Keisuke Nakase; Hidemasa Nakaminami; Takeaki Wajima; Nobukazu Hayashi; Norihisa Noguchi
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

4.  In vitro antibacterial activity of NB-003 against Propionibacterium acnes.

Authors:  J Pannu; A McCarthy; A Martin; T Hamouda; S Ciotti; L Ma; J Sutcliffe; J R Baker
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

5.  Activity of the novel macrolide BAL19403 against ribosomes from erythromycin-resistant Propionibacterium acnes.

Authors:  Jürg Dreier; Eva Amantea; Laurenz Kellenberger; Malcolm G P Page
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

6.  Susceptibility of Propionibacterium acnes isolated from patients with acne vulgaris to zinc ascorbate and antibiotics.

Authors:  Katsuhiro Iinuma; Norihisa Noguchi; Hidemasa Nakaminami; Masanori Sasatsu; Setsuko Nishijima; Isami Tsuboi
Journal:  Clin Cosmet Investig Dermatol       Date:  2011-10-05

7.  Complete genome sequence, lifestyle, and multi-drug resistance of the human pathogen Corynebacterium resistens DSM 45100 isolated from blood samples of a leukemia patient.

Authors:  Jasmin Schröder; Irena Maus; Katja Meyer; Stephanie Wördemann; Jochen Blom; Sebastian Jaenicke; Jessica Schneider; Eva Trost; Andreas Tauch
Journal:  BMC Genomics       Date:  2012-04-23       Impact factor: 3.969

8.  Draft Genome Sequences of the Two Unrelated Macrolide-Resistant Corynebacterium argentoratense Strains CNM 463/05 and CNM 601/08, Isolated from Patients in the University Hospital of León, Spain.

Authors:  Maria Isabel Fernández-Natal; Francisco Soriano; Alberto Acedo; Marta Hernandez; Andreas Tauch; David Rodríguez-Lázaro
Journal:  Genome Announc       Date:  2015-07-09

9.  An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains.

Authors:  Andrew McDowell; Emma Barnard; István Nagy; Anna Gao; Shuta Tomida; Huiying Li; Anne Eady; Jonathan Cove; Carl E Nord; Sheila Patrick
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

Review 10.  A Janus-Faced Bacterium: Host-Beneficial and -Detrimental Roles of Cutibacterium acnes.

Authors:  Holger Brüggemann; Llanos Salar-Vidal; Harald P M Gollnick; Rolf Lood
Journal:  Front Microbiol       Date:  2021-05-31       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.